
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
The Long Run with Luke Timmerman
00:00
Is Manufacturing a Top Priority?
As we've moved to more complex type of medicines, it started with bilogics. Manufacturing is becoming really the rate limiting step. And many companies are not able to get past the regulatory scrutiny just because they don't have witth clinical data.
Transcript
Play full episode